Moderna, Inc.
Budget
€200 — €0
EP Access
1
accredited persons
Staff
2
0.6 FTE
EU Grants
None
Mission & Goals
Moderna is a biotechnology company focused on developing and commercialising medicines and vaccines based on messenger RNA (mRNA) technology across multiple therapeutic areas including infections diseases, oncology and rare disease. The company's mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
EU Legislative Interests
Moderna's interest relates to legislative and policy initiatives affecting pharmaceutical innovation, public health, access, intellectual property, trade, manufacturing and supply chain resilience and initiatives relating to environmental, sustainability and digital. These include in particular: - Revision of the EU General Pharmaceutical Legislation - Critical Medicines Act - Implementation of Regulation 2021/2282 on Health Technology Assessment - Public health/biosafety preparedness and response frameworks (e.g. HERA) - EU Biotechnology Act (1 & 2) - EU Vaccines Strategy - Respiratory vaccines policies & procurement mechanisms - Pharmaceutical Strategy for Europe - Global Health Resilience Initiative - MDR - EU Health Dataspace - AI Act - Industry Accelerator Act
Communication Activities
Participation in high-level events Scientific publications and other articles in relation to mRNA technology
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
VE - Vaccines Europe (https://www.vaccineseurope.eu) Eucope - European Confederation of Pharmaceutical Entrepreneurs AISBL (www.eucope.org) IFPMA - International Federation of PHarmaceutical Manufacturers & Associations (www.ifpma.org) BIO - Biotechnology Innovation Organization (www.bio.org)
Organisation Members
N/A
Additional Information
The estimate of annual costs related to activities covered by the register includes personal costs, the relevant percentage of trade associations membership fees and relevant costs for intermediaries, as declared above.
Commissioner Meetings
No recorded meetings with EU commissioners.